LEQEMBI IQLIK(R) (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease
LEQEMBI IQLIK(R) (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease TOKYO and CAMBRIDGE, Mass., August 27, 2026 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB, announced today that once weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK®)is now available in…
bubmagAugust 27, 2026